ZFP Therapeutic

Sangamo BioSciences Receives $6.4 Million Strategic Partnership Award From California Institute for Regenerative Medicine (CIRM) to Develop ZFP Therapeutic for Beta-thalassemia
Yahoo/PR NewsWire
Fri, 05/24/13 - 10:44 am
Sangamo BioSciences
beta-thalassemia
stem cells
ZFP Therapeutic